Lifecore Biomedical Inc (LFCR)
R&D Expense Growth
-21.70%
Quarterly · Period ending:
LFCR R&D Expense Growth
Latest reported-21.70%period ending
Latest reported-21.70%period ending
LFCR Quarterly R&D Growth (QoQ) (0.00% → -21.70%)
Latest values, visible window
High-resolution chart · PNG
LFCR r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -21.7015% | |
| -20.8198% | |
| -6.6572% | |
| 2.8362% | |
| 6.289% | |
| -11.9854% | |
| 1.1569% | |
| -0.4147% | |
| 3.4318% | |
| -2.2367% | |
| -17.7147% | |
| 16.7413% | |
| 2.6183% | |
| -1.5378% | |
| 7.5389% | |
| 2.8% | |
| 7.7586% | |
| -0.9076% | |
| -27.375% | |
| 39.9349% | |
| -28.3437% | |
| 2.5518% | |
| -7.4197% | |
| -1.3833% | |
| -2.6577% | |
| 0.0354% | |
| -18.4918% | |
| 26.2678% | |
| 8.2116% | |
| -10.5895% | |
| -21.218% | |
| 15.5156% | |
| -7.6809% | |
| 24.0162% | |
| -23.5377% | |
| 76.5641% | |
| 2.4936% | |
| 1.3932% | |
| 6.7769% | |
| -4.2216% | |
| 15.3378% | |
| -12.3733% | |
| 16.243% | |
| -8.0912% | |
| -3.8356% | |
| 1.6713% | |
| 9.7188% | |
| -5.0493% | |
| -10.2137% | |
| -0.3634% | |
| -27.3756% | |
| 14.0645% | |
| 10.0331% | |
| -4.1289% | |
| -11.2364% | |
| 0.4044% | |
| 5.8194% | |
| 0.1715% | |
| -7.1628% | |
| 10.4615% | |
| 0.8869% | |
| 1.0305% | |
| 50.709% | |
| 48.2482% | |
| 6.051% | |
| 0.3195% | |
| -7.7603% | |
| 14.2536% | |
| 2.7682% | |
| -2.3649% | |
| 5.7143% | |
| 4.7382% | |
| 1.7766% | |
| -4.1363% | |
| 4.4473% | |
| 18.7029% | |
| -21.0714% | |
| 7.1429% | |
| 2.8871% | |
| 8.7019% | |
| -14.5122% | |
| 8.1794% | |
| 117.8161% | |
| -50.6383% | |
| 2.9197% | |
| -14.801% | |
| -13.8264% | |
| 5.9024% | |
| -11.6349% | |
| 8.2519% | |
| -7.2508% | |
| -7.1963% | |
| -2.1938% | |
| 29.1617% | |
| -4.9383% | |
| 7.0913% | |
| 755.1181% | |
| -110.7627% | |
| 7.078% | |
| -1.0772% |